Interaction of Histone Acetylases and Deacetylases In Vivo
Abstract
Having opposing enzymatic activities, histone acetylases (HATs) and deacetylases affect chromatin and regulate transcription. The activities of the two enzymes are thought to be balanced in the cell by an unknown mechanism that may involve their direct interaction. Using fluorescence resonance energy transfer analysis, we demonstrated that the acetylase PCAF and histone deacetylase 1 (HDAC1) are in close spatial proximity in living cells, compatible with their physical interaction. In agreement, coimmunoprecipitation assays demonstrated that endogenous HDACs are associated with PCAF and another acetylase, GCN5, in HeLa cells. We found by glycerol gradient sedimentation analysis that HATs are integrated into a large multiprotein HDAC complex that is distinct from the previously described HDAC complexes containing mSin3A, Mi-2/NRD, or CoREST. This HDAC-HAT association is partly accounted for by a direct protein-protein interaction observed in vitro. The HDAC-HAT complex may play a role in establishing a dynamic equilibrium of the two enzymes in vivo.
Specific lysines on the core histones are acetylated by a series of histone acetylases (HATs). The status of acetylation constitutes one basis for the histone code, an important basis of chromatin-mediated regulatory processes, including transcription, replication, and chromosome dynamics (12, 23, 29). Acetylation of histone tails can be reversed by a diverse series of histone deacetylases (5, 15).
Both HATs and histone deacetylases are classified into several distinct groups. The GNAT family of HATs, one of the best-studied families, is conserved throughout eukaryotes (23, 28). In mammalian species there are two GNAT members, GCN5 and PCAF. They are structurally similar to each other and are expressed in overlapping sets of cells and tissues. They predominantly regulate acetylation of histone H3 and are generally involved in transcriptional activation (12, 25, 39). Both GCN5 and PCAF form large multiprotein complexes whose compositions are also conserved (9, 21, 23, 28). Among histone deacetylases, class I histone deacetylases (HDACs) were the first to be identified and are conserved from yeasts such as Saccharomyces cerevisiae to humans. Four HDACs are currently known in humans: HDAC1, HDAC2, HDAC3, and HDAC8 (15). These histone deacetylases are generally associated with transcriptional repression mediated by various DNA binding transcription factors (5, 15, 20, 24). HDAC1 and HDAC2 form at least three distinct complexes that contain representative factors, mSin3A, Mi-2/NRD, and CoREST/kiaa0071 (13, 32, 40, 44, 45, 46). HDAC3 also forms a complex that contains N-CoR and SMRT, among other components (10, 16, 36).
Although rapid progress has been made on understanding the structure and function of individual HATs and HDACs, a remaining question is how the activities of these two enzymes, which exert opposite functions, are mutually balanced in the cell (23). A series of genetic studies and promoter analyses suggest that the two enzymes may not act independently and that their activities in some cases may be linked to one another (22, 34, 37). Other lines of evidence indicate that some HATs and HDACs occupy the common space in the nucleus and coordinately regulate the same set of target genes. For example, transcriptional activation mediated by nuclear receptors such as retinoic acid receptor and retinoid X receptor involves ligand-dependent association and dissociation of HAT and HDAC, respectively, on a given promoter (2, 38). Coordinated activity of the two enzymes may also be inferred for cell growth-regulated genes controlled by E2F, whose promoter activity is repressed by the HDAC-associated retinoblastoma protein but is activated by subsequent HAT recruitment (5). Furthermore, YY1 and Sp1 interact with both HATs and HDACs, thereby acquiring an activator or repressor function depending on promoter context and other factors (5). A close interrelationship between the two enzymes may also be presumed, based on the earlier observation that histones are rapidly acetylated and deacetylated with a half-life of less than 10 min in some regions of a nucleus while in other regions histone acetylation is turned over more slowly (4, 6). More-recent studies demonstrate that HATs and HDACs are engaged in a rapid cycle of global histone acetylation and deacetylation that affects the whole yeast genome (1, 14, 34). The global, untargeted alteration of histone acetylation is likely to be critical for rapid reversal of targeted chromatin modification in a specific promoter associated with transcriptional activation and/or repression (14, 34).
In this work we wished to address the mechanisms that may balance the activities of the two enzymes. We surmised that among the mechanisms that help coordinate their activities, one might involve a physical interaction between the two enzymes. To search for evidence indicating the presence of HDAC-HAT interaction in vivo, we first employed a novel flow cytometry technique based on fluorescence resonance energy transfer (FRET) (26, 30). This technique allows an assessment of molecular interactions between two proteins in the living cell. Although not heretofore applied extensively to the analysis of nuclear events, this approach provides a powerful new tool to investigate the molecular behavior of transcription factors and chromatin modifiers in the nucleus. By introducing PCAF and HDAC1 labeled with distinct fluorochromes into HeLa cells, we observed clear FRET signals ascribable to their physical proximity. Using coimmunoprecipitation assays, it was shown that HDAC1, HDAC2, and HDAC3 are all associated with GCN5 and PCAF in HeLa cells. Glycerol gradient sedimentation analysis of HDAC1 complexes revealed that GCN5 is contained in a large multiprotein complex(es) distinct from the three HDAC complexes reported before. In vitro binding analysis indicated that the HATs are incorporated into the HDAC complex(es) at least in part by directly binding to HDACs. Finally, we present evidence suggesting that HDAC-HAT interactions occur in a dynamic fashion depending on the physiological state of cells. Taken together, these results point to a mechanism that internally maintains HDAC-HAT equilibrium in the cell.
Acknowledgments
We thank S. Schreiber and E. Seto for HDAC plasmids, T. Howard for viral transduction of HeLa cells, and R. Swofford and K. Holmes for flow cytometry analysis.
REFERENCES
References
- 1. Berger, SL. 2000. Local or global? Nature408:412-415. [[PubMed][Google Scholar]
- 2. Blanco, J. C., S. Minucci, J. Lu, X. J. Yang, K. K. Walker, H. Chen, R. M. Evans, Y. Nakatani, and K. Ozato. 1998. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev.12:1638-1651.
- 3. Chang, D. H., C. Angelin-Duclos, and K. Calame. 2000. BLIMP-1: trigger for differentiation of myeloid lineage. Nat. Immunol.1:169-176. [[PubMed]
- 4. Covault, J., and RChalkley. 1980. The identification of distinct populations of acetylated histone. J. Biol. Chem.255:9110-9116. [[PubMed][Google Scholar]
- 5. Cress, W. D., and E. Seto. 2000. Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol.184:1-16. [[PubMed]
- 6. Davie, JR. 1998. Covalent modifications of histones: expression from chromatin templates. Curr. Opin. Genet. Dev.8:173-178. [[PubMed][Google Scholar]
- 7. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res.11:1475-1489.
- 8. Francastel, C., D. Schubeler, D. I. Martin, and M. Groudine. 2000. Nuclear compartmentalization and gene activity. Nat. Rev. Mol. Cell Biol.1:137-143. [[PubMed]
- 9. Grant, P. A., L. Duggan, J. Cote, S. M. Roberts, J. E. Brownell, R. Candau, R. Ohba, T. Owen-Hughes, C. D. Allis, F. Winston, S. L. Berger, and J. L. Workman. 1997. Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev.11:1640-1650. [[PubMed]
- 10. Guenther, M. G., O. Barak, and M. A. Lazar. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol.21:6091-6101.
- 11. Heinzel, T., R. M. Lavinsky, T. M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W. M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature387:43-48. [[PubMed]
- 12. Howe, L., C. E. Brown, T. Lechner, and J. L. Workman. 1999. Histone acetyltransferase complexes and their link to transcription. Crit. Rev. Eukaryot. Gene Expr.9:231-243. [[PubMed]
- 13. Humphrey, G. W., Y. Wang, V. R. Russanova, T. Hirai, J. Qin, Y. Nakatani, and B. H. Howard. 2001. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem.276:6817-6824. [[PubMed]
- 14. Katan-Khaykovich, Y., and KStruhl. 2002. Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors. Genes Dev.16:743-752. [Google Scholar]
- 15. Khochbin, S., A. Verdel, C. Lemercier, and D. Seigneurin-Berny. 2001. Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev.11:162-166. [[PubMed]
- 16. Li, J., J. Wang, Z. Nawaz, J. M. Liu, J. Qin, and J. Wong. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J.19:4342-4350.
- 17. Masumi, A., and KOzato. 2001. Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment. J. Biol. Chem.276:20973-20980. [[PubMed][Google Scholar]
- 18. Masumi, A., I. M. Wang, B. Lefebvre, X. J. Yang, Y. Nakatani, and K. Ozato. 1999. The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol. Cell. Biol.19:1810-1820.
- 19. Miyawaki, A., and R. Y. Tsien. 2000. Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein. Methods Enzymol.327:472-500. [[PubMed]
- 20. Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell89:373-380. [[PubMed]
- 21. Ogryzko, V. V., T. Kotani, X. Zhang, R. L. Schlitz, T. Howard, X. J. Yang, B. H. Howard, J. Qin, and Y. Nakatani. 1998. Histone-like TAFs within the PCAF histone acetylase complex. Cell94:35-44. [[PubMed]
- 22. Perez-Martin, J., and A. D. Johnson. 1998. Mutations in chromatin components suppress a defect of Gcn5 protein in Saccharomyces cerevisiae. Mol. Cell. Biol.18:1049-1054.
- 23. Roth, S. Y., J. M. Denu, and C. D. Allis. 2001. Histone acetyltransferases. Annu. Rev. Biochem.70:81-120. [[PubMed]
- 24. Sasaki, S., L. A. Lesoon-Wood, A. Dey, T. Kuwata, B. D. Weintraub, G. Humphrey, W. M. Yang, E. Seto, P. M. Yen, B. H. Howard, and K. Ozato. 1999. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. EMBO J.18:5389-5398.
- 25. Schiltz, R. L., C. A. Mizzen, A. Vassilev, R. G. Cook, C. D. Allis, and Y. Nakatani. 1999. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem.274:1189-1192. [[PubMed]
- 26. Siegel, R. M., J. K. Frederiksen, D. A. Zacharias, F. K. Chan, M. Johnson, D. Lynch, R. Y. Tsien, and M. J. Lenardo. 2000. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science288:2354-2357. [[PubMed]
- 27. Smith, E. R., J. M. Belote, R. L. Schiltz, X. J. Yang, P. A. Moore, S. L. Berger, Y. Nakatani, and C. D. Allis. 1998. Cloning of Drosophila GCN5: conserved features among metazoan GCN5 family members. Nucleic Acids Res.26:2948-2954.
- 28. Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev.64:435-459.
- 29. Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature403:41-45. [[PubMed]
- 30. Stryer, L. 1978. Fluorescence energy transfer as a spectroscopic ruler. Annu. Rev. Biochem.47:819-846. [[PubMed]
- 31. Taunton, J., C. A. Hassig, and S. L. Schreiber. 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science272:408-411. [[PubMed]
- 32. Tong, J. K., C. A. Hassig, G. R. Schnitzler, R. E. Kingston, and S. L. Schreiber. 1998. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature395:917-921. [[PubMed]
- 33. Vassilev, A., J. Yamauchi, T. Kotani, C. Prives, M. L. Avantaggiati, J. Qin, and Y. Nakatani. 1998. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Mol. Cell2:869-875. [[PubMed]
- 34. Vogelauer, M., J. Wu, N. Suka, and M. Grunstein. 2000. Global histone acetylation and deacetylation in yeast. Nature408:495-498. [[PubMed]
- 35. Wade, P. A., A. Gegonne, P. L. Jones, E. Ballestar, F. Aubry, and A. P. Wolffe. 1999. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet.23:62-66. [[PubMed]
- 36. Wen, Y. D., V. Perissi, L. M. Staszewski, W. M. Yang, A. Krones, C. K. Glass, M. G. Rosenfeld, and E. Seto. 2000. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA97:7202-7207.
- 37. Wittschieben, B. O., G. Otero, T. de Bizemont, J. Fellows, H. Erdjument-Bromage, R. Ohba, Y. Li, C. D. Allis, P. Tempst, and J. Q. Svejstrup. 1999. A novel histone acetyltransferase is an integral subunit of elongating RNA polymerase II holoenzyme. Mol. Cell4:123-128. [[PubMed]
- 38. Wolffe, AP. 1997. Transcriptional control. Sinful repression. Nature387:16-17. [[PubMed][Google Scholar]
- 39. Xu, W., D. G. Edmondson, and S. Y. Roth. 1998. Mammalian GCN5 and P/CAF acetyltransferases have homologous amino-terminal domains important for recognition of nucleosomal substrates. Mol. Cell. Biol.18:5659-5669.
- 40. Xue, Y., J. Wong, G. T. Moreno, M. K. Young, J. Cote, and W. Wang. 1998. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell2:851-861. [[PubMed]
- 41. Yang, W. M., C. Inouye, Y. Zeng, D. Bearss, and E. Seto. 1996. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA93:12845-12850.
- 42. Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature382:319-324. [[PubMed]
- 43. Yazdi, P. T., Y. Wang, S. Zhao, N. Patel, E. Y. Lee, and J. Qin. 2002. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev.16:571-582.
- 44. You, A., J. K. Tong, C. M. Grozinger, and S. L. Schreiber. 2001. CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc. Natl. Acad. Sci. USA98:1454-1458.
- 45. Zhang, Y., R. Iratni, H. Erdjument-Bromage, P. Tempst, and D. Reinberg. 1997. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell89:357-364. [[PubMed]
- 46. Zhang, Y., H. H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird, and D. Reinberg. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev.13:1924-1935.






